Biobot Analytics
PrivateLast Round
VC Round
Jun 18, 2025
Est. Valuation
$1.71M
Total Funding Raised
$30.13M
Company Overview
Biobot Analytics is a biotechnology and data analytics company that specializes in wastewater-based epidemiology to provide population-level health intelligence.
Sector
Healthcare & Life Sciences
Verticals
Environmental Monitoring, Healthcare Analytics, Biotechnology
Business Model
B2G
Customer Profile
Data as a Service, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biobot Analytics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Biobot Analytics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 18, 2025 | ||||
| Grant | Sep 21, 2023 | ||||
| Series A | Oct 22, 2021 | ||||
| Seed | Apr 21, 2020 | ||||
| Seed | May 8, 2018 | ||||
Accelerator | Jan 1, 2018 |
Biobot Analytics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Refactor Capital | Seed |
| National Institute on Drug Abuse (NIDA) | Grant |
| The Engine | Series A, Seed |
| Engine Ventures | Seed |
| Hyperplane | VC Round |
| Atreides Management | VC Round |
| Plum Alley Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 21, 2023
$800K grant from National Institute on Drug Abuse (NIDA)
- Oct 22, 2021
$20M round led by Thursday Ventures.
Biobot Analytics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Biobot Analytics's valuation, stock price, and market status.